MEDPLUSNSEMedplus Health Services LimitedMinimalNeutral
Announced Fri, 22 May · 11:28 IST

Lone Furrow Investment Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

MEDPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.0%1-day move
₹950.30
prior close
₹928.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.1+0.1-1.2-5.0-6.7-7.1-5.1-7.7-5.3-8.5-12.1-25.2
Up moveDown movePending
AI summary

Lone Furrow Investments Private Limited, the promoter of Medplus Health Services Limited, has submitted a declaration to the exchanges confirming that it has not created any new encumbrance (pledge) on its shareholding in the company during Financial Year 2025-26, beyond what was already disclosed earlier. The declaration is made under Regulation 31(4) of the SEBI SAST Regulations, which requires promoters to periodically disclose details of share encumbrances. Gangadi Madhukar Reddy, Director of Lone Furrow, signed the declaration dated 04/04/2026. This is a standard regulatory compliance filing submitted to both BSE and NSE.

Likely market impact

A no-encumbrance declaration is generally a neutral-to-slightly-positive signal for retail shareholders, indicating the promoter has not pledged additional shares for borrowing, which reduces the risk of forced selling. However, this is a routine compliance filing and does not by itself indicate any material change in the company's operations or financials.